Sai Life Sciences Ltd

This Children's Day, we celebrated with our annual painting competition, Chitrakaar, where children were invited to paint from the heart. The canvases came alive with creativity—some painted messages like 'Be the solution to pollution,' others brought characters like Doraemon to life, while some created beautiful portraits of national leaders, others sketched gods and goddesses. Each painting was unique, reflecting their imagination, creativity, and the pure joy they find in the world around them. #sailifesciences #childrensday #employeeengagement #creativity #pharma

Nathalie Huther participated in a panel at the Kadans Innovation Summit organized by Kadans Science Partner in London, joining industry leaders to explore the opportunities and challenges of advancing life sciences manufacturing In Europe. The discussion centered on implementing innovative solutions to enhance efficiency and speed, while also addressing sustainability goals and ensuring resilience against potential supply chain disruptions. #sailifesciences #europe #pharma #cdmo #cro #supplychain

On most days, Jomy Jose is found in the pathology lab, evaluating compounds for their toxicity, while on some days, she engages in academic pursuits. Jomy has contributed a chapter titled ‘Methods in Toxicologic Pathology' to 'Animal Models in Research: Principles and Practice’, published by Springer. This book, designed for scientists in pharmaceuticals, CROs, and CDMOs, highlights how understanding pathological methodologies can improve the assessment of compound toxicity. Effective evaluation of blood, body fluids, and tissue samples helps pinpoint target organs and determine safe dosage levels, addressing a major cause of drug attrition during pharmaceutical development. We hope that the scientific community will find value in Jomy’s work. #sailifesciences #cro #cdmo #pharma #pathology #academicwriting

Sai Life Sciences had an eventful Pharma Integrates 2024! Nathalie Huther moderated an engaging panel on ‘The Three Cs – CDMO, CRO, and Change,’ which featured speakers who shared their expertise on navigating the evolving landscape of contract development, manufacturing, and outsourcing. The discussion highlighted how CDMOs & CROs are adapting to regulatory, technological, and market shifts to meet the changing needs of the industry. Emma Hunt joined a panel discussing ‘How can pharma supply chains and partnerships respond to the dynamics of the pharmaceutical market?’. Key takeaways included the need for increased agility, the role of collaboration in risk mitigation and using digital platforms to achieve this. We thank all the attendees, speakers, and visitors for connecting with Sai Life Sciences team at the event. #sailifesciences #drugdevelopment #drugdiscovery #cdmo #cro #pharma #pharmaintegrates

Victoria Steadman, Carlos Pedraza, and Kelly Barrett from Sai Life Sciences will be attending the Proventa International Medicinal Chemistry Strategy Meeting East Coast USA 2024 on November 13. At the event, Victoria will moderate a roundtable discussion on 'Lead Optimization for bRo5 Molecules', while Kelly will lead a discussion on 'Improving Efficiency in Design and Synthesis'. Sai Life Sciences' Discovery services are designed to accelerate the journey from 'Concept to Clinic' with speed and high-quality data. Our integrated approach combines Computational Chemistry, Medicinal Chemistry, Biology, DMPK, and Toxicology under one roof to fast-track the DMTA (Design, Make, Test, and Analyze) cycle. Over the past five years, we have supported more than 140 small-molecule discovery programs. To learn more about our services, meet our team at the event. #sailifesciences #drugdiscovery #drugdevelopment #medicinalchemistry #chemistry #cro #cdmo #pharma

Victoria Steadman, Jonathan Castillo, Carlos Pedraza, and Kelly Barrett from Sai Life Sciences will be attending the Proventa International Drug Discovery Biology Strategy Meeting East Coast 2024 on November 12. At the event, Jonathan will moderate a roundtable discussion on Structural Biology & Biophysics, while Carlos will lead a discussion on Target Identification & HIT Validation. Sai Life Sciences’ Discovery services, designed to accelerate the journey from ‘Concept to Clinic’ with speed and high-quality data, integrate Computational Chemistry, Medicinal Chemistry, Biology, DMPK, and Toxicology—all under one roof—to fast-track the DMTA (Design, Make, Test, and Analyze) cycle. Over the past five years, we have supported more than 140 small-molecule discovery programs. To learn more about our services, meet our team at the event. #sailifesciences #drugdiscovery #drugdevelopment #biology #cro #cdmo #pharma

Our team comprising Sreenivasulu Bandaru, S Sangaraju, Stephen H., Nathalie Huther, and Emma Hunt will be at BOS Manchester 2024 during November 26-27. Sai Life Sciences is India’s fastest-growing Contract Research, Development, and Manufacturing Organization (CRDMO) (In terms of revenue CAGR and EBITDA CAGR over FY22-24). With 25 years of experience, the company has collaborated with global pharmaceutical and biotech innovators to enhance the drug discovery, development, and manufacturing value chain for small molecule new chemical entities (NCEs). As of March 2024, Sai Life Sciences has partnered with over 280 clients, including 18 of the top 25 global pharmaceutical companies (based on 2023 revenue). The company has integrated global R&D and manufacturing facilities in the USA, UK, and India, supported by a workforce of over 2,800 employees across these countries and Japan. To learn more about the company, meet our team at Stand 42 at BOS Manchester 2024. #sailifesciences #bosmanchester #drugdevelopment #drugdiscovery #bio2business #cro #cdmo #pharma

Vamsi Madgula and Veena Madappa will be at the 17th Symposium on Pharmacokinetics and Drug Metabolism in Mölndal, Sweden, during November 12-13. Earlier this year, we expanded our DMPK capabilities to better serve the needs of global pharmaceutical clients. This expansion included a new 25,000 sq. ft. facility featuring state-of-the-art labs and advanced instrumentation with high-end automation. We also expanded our team nearly threefold, bringing in top talent from around the world. This enhancement underscores our commitment to delivering ‘Scale, Speed & Solution’ tailored to meet our clients' specific needs. To learn more about how we can help you accelerate the pace of your drug discovery programs with advanced DMPK services, please meet our team. #sailifesciences #drugdiscovery #drugdevelopment #dmpk #cro #cdmo #pharma

We recently hosted Masters of Pharmacy (M. Pharm) students from GITAM Deemed University at our Integrated R&D site, Hyderabad. This visit aimed to provide a comprehensive overview of our operations. During their visit, the students toured our Biology, DMPK, and Vivarium facilities, guided by our scientists. They learned about the various steps involved in drug discovery, gaining valuable insights into the life of a scientist and the exciting possibilities ahead. #sailifesciences #industrialvisit #pharma #cro #cdmo #drugdiscovery

Career opportunity at Sai Life Sciences. Please scan the QR code for details. #sailifesciences #pharmajobs #cro #cdmo